Evaluating gastric activity in children with gastrointestinal symptoms
Official title: Body Surface Gastric Mapping (BSGM) to Evaluate Patients With Gastrointestinal (GI) Symptoms
Run by Children's Hospital of Philadelphia · NCT05880199 · Data updated 2026-11-12
This study tests how stomach activity in children with tummy problems compares to healthy kids to see if a new device can help understand their symptoms better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 8 Years to 25 Years |
| Sex | All |
| Enrollment | 685 (estimated) |
| Sponsor | Children's Hospital of Philadelphia Academic / other |
| Locations | 5 sites (San Diego, California and 4 other locations) |
| Status | Recruiting |
| Started | October 1, 2021 |
| Main results expected | December 31, 2027 |
| Study ends | June 30, 2028 |
| Registry record updated | February 10, 2026 |
| Trial ID | NCT05880199 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include males and females aged 8 to 25 years with confirmed functional gastrointestinal or motility disorders.
✕Probably not a fit
Patients with skin allergies, open wounds, or conditions that contraindicate fasting may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate gastric myoelectric activity in children experiencing gastrointestinal symptoms. Using a non-invasive Body Surface Gastric Mapping (BSGM) device, the study will record stomach activity for up to 4 hours while participants log their real-time symptoms. Researchers will compare the gastric patterns of healthy children with those of children diagnosed with gastrointestinal motility disorders to identify abnormal patterns and optimize the use of the BSGM device as a diagnostic tool.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic methods for gastrointestinal disorders in children.
How similar studies have gone: Other studies have shown promise in using non-invasive gastric mapping techniques, but this specific approach is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for Cases 1. Males or females age 8 to 25 years. 2. Females ≥11 years of age or who have reached menarche must have a negative urine pregnancy test. 3. Confirmed diagnosis of a Functional Gastrointestinal and/or Motility Disorder OR undergoing one of the following procedures as part of their clinical care at one of the participating centers: 1. HRVB 2. PENFS 3. ADM 4. Colonic Manometry 5. Pyloric Botox 6. Pyloric Dilation 7. Gastric Scintigraphy 8. GES 9. gammaCore 4. Those with a body mass index of \< 35. 5. Parental/guardian permission (informed consent) and if appropriate, child assent. Exclusion Criteria for Cases 1. History of skin allergies or a history of extreme sensitivity to cosmetics or lotions. Currently open wounds, abrasions, infected or inflamed abdominal skin. (Please note, majority of feeding tubes can be accommodated by the array placement.) 2. Pregnant women. 3. Those with any condition, where fasting is not recommended by a physician. 4. Any allergies to foods that may be present in the standardized meal that cannot be accommodated with an acceptable substitute meal. 5. Those with physical limitations, who are not able to maintain a relaxed reclined position for the study visit duration. 6. Those with major developmental delay or cognitive impairment, who are not able to report their symptoms/feelings in the questionnaires. 7. Those with GI motility disorders that are limited in the esophagus, and the gastric mapping is restricted to capture relevant data based on the investigator's discretion. 8. Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures. Inclusion Criteria for Controls 1. Males or females age 8 to 25 years. 2. Females ≥11 years of age or who have reached menarche must have a negative urine pregnancy test. 3. Do not have an active Functional Gastrointestinal disorder (FGID) diagnosis and will not be undergoing any procedures outlined in the recruitment plan in the near future. 4. Those with a body mass index of \< 35. 5. Individuals may include siblings of those with FGIDs. 6. Parental/guardian permission (informed consent) and if appropriate, child assent. Exclusion Criteria for Controls 1. History of skin allergies or a history of extreme sensitivity to cosmetics or lotions. Currently open wounds, abrasions, infected or inflamed abdominal skin. 2. Pregnant women. 3. Those with any condition, where fasting is not recommended by a physician. 4. Allergies to foods that may be included in the standardized meal that cannot be accommodated with an acceptable substitute meal. 5. Those with physical limitations, who are not able to maintain a relaxed reclined position for the study duration. 6. Those with major developmental delay or cognitive impairment, who are not able to report their symptoms/feelings in the questionnaires. 7. Those with GI motility disorders that are limited in the esophagus, and the gastric mapping is restricted to capture relevant data based on the investigator's discretion. 8. Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
Where it's running
-
Alliant International University
San Diego, California, United States Recruiting -
Children's Mercy Hospital
Kansas City, Missouri, United States Recruiting -
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States Recruiting -
Nationwide Children's Hospital
Columbus, Ohio, United States Recruiting -
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Hayat Mousa, MD — Children's Hospital of Philadelphia
- Study coordinator: Hayat Mousa, MD
- Email: MousaH@chop.edu
- Phone: 215-590-1000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Testing combined H1 and H2 antihistamines for functional dyspepsia
We’re testing whether a combination of an H1 antihistamine and an H2 antihistamine helps people with functional dyspepsia more than a single antihistamine.
-
Gastric-focused ultrasound to see if it changes stomach activity and symptoms
This study tests whether noninvasive stomach-focused ultrasound can alter post-meal stomach electrical activity and symptoms in adults with gastroparesis or delayed gastric emptying, using a sham control in a crossover design.
-
Gastric emptying and feeding tolerance in ICU patients by vasopressor dose
This study tests whether vasopressor dose affects how well stomach contents empty during tube feeding in critically ill patients.
-
Virtual poetry workshops to boost well-being for people with digestive symptoms
This study tests whether participating in online poetry workshops can improve emotional well-being for adults with chronic digestive symptoms and anxiety or depression.
-
Sacral nerve stimulation for children with bowel motility problems
This project tests sacral neuromodulation in children aged 3–18 with gastrointestinal motility disorders to see if imaging-guided, personalized implantation improves symptoms.
-
Holy basil (tulsi) to treat dyspepsia
This study will test whether taking 300 mg of holy basil extract once daily for 28 days can reduce stomach inflammation and improve symptoms in adults with dyspepsia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.